Stocks and Investing
Stocks and Investing
Wed, December 14, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Justin Bowers Initiated (WST) at Hold and Held Target at $250 on, Dec 14th, 2022
Justin Bowers of Deutsche Bank, Initiated "West Pharmaceutical Services, Inc." (WST) at Hold and Held Target at $250 on, Dec 14th, 2022.
Justin has made no other calls on WST in the last 4 months.
There are 3 other peers that have a rating on WST. Out of the 3 peers that are also analyzing WST, 2 agree with Justin's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- John Sourbeer of "UBS" Initiated at Hold and Held Target at $250 on, Wednesday, November 30th, 2022
- Derik De Bruin of "B of A Securities" Downgraded from Strong Buy to Hold and Decreased Target to $250 on, Friday, October 28th, 2022
This is the rating of the analyst that currently disagrees with Justin
- Paul Knight of "Keybanc" Maintained at Buy with Decreased Target to $315 on, Friday, December 2nd, 2022
Contributing Sources